Cited by 320Brain Metastases and TreatmentFerroptosis and cancer prognosisIron Metabolism and Disorders

Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis.

Open access
Chi, Yudan, Remsik, Jan, Kiseliovas, Vaidotas, Derderian, Camille, Sener, Ugur, Alghader, Majdi, Saadeh, Fadi, Nikishina, Katie +6 more·2020·Science

Abstract

The tumor microenvironment plays a critical regulatory role in cancer progression, especially in central nervous system metastases. Cancer cells within the cerebrospinal fluid (CSF)-filled leptomeninges face substantial microenvironmental challenges, including inflammation and sparse micronutrients. To investigate the mechanism by which cancer cells in these leptomeningeal metastases (LM) overcome these constraints, we subjected CSF from five patients with LM to single-cell RNA sequencing. We found that cancer cells, but not macrophages, within the CSF express the iron-binding protein lipocalin-2 (LCN2) and its receptor SCL22A17. These macrophages generate inflammatory cytokines that induce cancer cell LCN2 expression but do not generate LCN2 themselves. In mouse models of LM, cancer cell growth is supported by the LCN2/SLC22A17 system and is inhibited by iron chelation therapy. Thus, cancer cells appear to survive in the CSF by outcompeting macrophages for iron.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.aaz2193

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • scRNAseq analysis done on tumor cells isolated from the leptomeninges of patients with metastatic growth showed high expression of the iron-binding protein lipocalin-2 (Lcn2) and its receptor SLC22A17, and Lcn2 expression, which is induced by macrophage cytokine release, allows tumor cells to grow more effectively in the low nutrient CSF environment.

    “scRNAseq analysis done on tumor cells isolated from the leptomeninges of patients with metastatic growth showed high expression of the iron-binding protein lipocalin-2 (Lcn2) its receptor SLC22A17”

    From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Chi et al., 2020

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chi, Y., Remsik, J., Kiseliovas, V., Derderian, C., Sener, U., Alghader, M., Saadeh, F., Nikishina, K., Bale, T., Iacobuzio-Donahue, C., Thomas, T., Pe’er, D., Mazutis, L., & Boire, A.
Affiliations
  • Memorial Sloan Kettering Cancer Center (US)
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Columbia University (US)
  • Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Corresponding author
Boire, Adrienne
Venue
Science
Published
2020-07-17
Volume
369
Issue
6501
Pages
276-282
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W3043398874
Cited by
320
References
47
Citations by year
2026: 46 · 2025: 69 · 2024: 69 · 2023: 56 · 2022: 37 · 2021: 34 · 2020: 9
FWCI
19.12
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (R35 CA220508, 1U2CCA233284, P30 CA008748)
  • Pew Charitable Trusts (GC241069)
  • Damon Runyon Cancer Research Foundation (GC240764)
  • American Brain Tumor Association (BRF1900019)
  • Pershing Square Sohn Cancer Research Alliance (GC239280)
  • The Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center
  • Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (n/a)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Brain Metastases and Treatment
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Keywords
leptomeningeal metastasis, neutrophil gelatinase-associated lipocalin, SLC22A17, iron acquisition, tumor microenvironment, cerebrospinal fluid, cancer-associated macrophages, iron chelation therapy, central nervous system metastasis, single-cell RNA sequencing
MeSH terms
Lipocalin-2, Animals, Humans, Iron, Macrophages, Meningeal Neoplasms, Mice, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review